BioLineRx Ltd. (BLRX) is priced at $3.33 after the most recent trading session. At the very opening of the session, the stock price was $3.16 and reached a high price of $3.2585, prior to closing the session it reached the value of $3.22. The stock touched a low price of $3.16.
Recently in News on May 26, 2021, BioLineRx Reports First Quarter 2021 Financial Results and Provides Corporate Update. – Phase 3 GENESIS study in stem-cell mobilization (SCM) demonstrated highly statistically significant positive results across all primary and secondary endpoints -. You can read further details here
BioLineRx Ltd. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $6.34 on 05/04/21, with the lowest value was $2.32 for the same time period, recorded on 01/27/21.
BioLineRx Ltd. (BLRX) full year performance was 61.81%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, BioLineRx Ltd. shares are logging -47.48% during the 52-week period from high price, and 137.86% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.40 and $6.34.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 647247 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the BioLineRx Ltd. (BLRX) recorded performance in the market was 27.78%, having the revenues showcasing 15.83% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 148.38M, as it employees total of 38 workers.
Specialists analysis on BioLineRx Ltd. (BLRX)
During the last month, 2 analysts gave the BioLineRx Ltd. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.97, with a change in the price was noted +0.23. In a similar fashion, BioLineRx Ltd. posted a movement of +7.28% for the period of last 100 days, recording 3,834,112 in trading volumes.
Trends and Technical analysis: BioLineRx Ltd. (BLRX)
Raw Stochastic average of BioLineRx Ltd. in the period of last 50 days is set at 77.01%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 75.34%. In the last 20 days, the company’s Stochastic %K was 63.28% and its Stochastic %D was recorded 58.57%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 27.78%. Additionally, trading for the stock in the period of the last six months notably improved by 31.43%, alongside a boost of 61.81% for the period of the last 12 months. The shares increased approximately by 5.57% in the 7-day charts and went down by 20.15% in the period of the last 30 days. Common stock shares were driven by 15.83% during last recorded quarter.